Clinical trial

A Dose Escalating Study to Assess the Safety and Tolerability of GT-001

NCT03490786

Study summary

ClinicalTrials.gov

A Dose Escalating Study to Assess the Safety and Tolerability of GT-001

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention GT-001 Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-07-16

PhasePHASE1

Conditions

Feeding and Eating Disordersunresolved

Interventions

GT-001DRUG

Sponsors & collaborators

Gila Therapeutics, Inc.lead sponsor

Mapped research locations

TustinCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03490786 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.